ArticleInternational journal of physiology, pathophysiology and pharmacology2022
Expected cost effectiveness of the fourth dose of COVID-19 vaccine against the omicron variant of COVID-19: a preliminary report.
Rujittika Mungmunpuntipantip et al.PubMed ↗Full text ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it